A Better Way Psychiatry & TMS
Mental health clinic in Cerritos, California.
No reviews yet
View DetailsSpravato (Esketamine) in Cerritos, California
Compare 2 Spravato (Esketamine) clinics in Cerritos, California that offer care for treatment-resistant depression and major depressive disorder. Review services, ratings, and contact details to find the right provider near you.
Clinics
2 clinics shown
Mindpath Health Psychiatrists & Therapists - Cerritos
Mindpath Health operates an outpatient psychiatry practice in Cerritos on Park Plaza Drive, providing psychiatric evaluations, medication management, and psychotherapy for adults with mood, anxiety, and other mental health conditions. The practice does not list TMS, esketamine, or ketamine treatments in available data; patients seeking those interventions should confirm availability directly with the clinic. Mindpath Health maintains multiple locations across California, with this site serving the greater Los Angeles and Orange County areas.
No reviews yetView Details
About Spravato (Esketamine)
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.